Summary
For Year 2026-27, SMS Pharmaceuticals reports the following shareholding: Total Promoters at 68.07%, Mutual Fund at 2.96%, Insurance at 0%, Foreign Institutional Investors at 0.31%, Domestic Institutional Investors at 0.05%, and Retail at 28.61%. This breakdown provides a quick snapshot of ownership distribution for SMS Pharmaceuticals in 2026-27.
SMS Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in SMS Pharmaceuticals stands at 68.07% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of SMS Pharmaceuticals is 0.31% and 0.05% respectively.
The retail shareholding of the SMS Pharmaceuticals is 28.61%.
Changes in shareholding patterns of SMS Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of SMS Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
SMS Pharmaceuticals Associated Pages
